MannKind Corp (MNKD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MannKind Corp (MNKD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7269
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. The product consists of a dry powder formulation of human insulin delivered from a small and portable inhaler. The company develops products based on its proprietary Technosphere formulation technology. It has manufacturing facility in Danbury, Connecticut and sells its product through wholesale distributors and specialty pharmacies. MannKind is headquartered in California, the US.

MannKind Corp (MNKD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MannKind Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MannKind Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MannKind Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MannKind Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
MannKind Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
MannKind Corp, Medical Equipment, Deal Details 11
Partnerships 11
MannKind and One Drop to Enter into Agreement 11
United Therapeutics to Enter into Licensing Agreement with MannKind 12
Equity Offering 13
MannKind Raises USD28 Million in Private Placement of Shares 13
Mannkind to Raise USD61 Million in Private Placement of Shares 15
MannKind Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 17
MannKind Raises USD36.2 Million in Private Placement of Shares 18
Mannkind Raises USD50 Million in Private Placment of Shares 19
MannKind Announces Public Offering Of Common Stock For US$50 Million 21
MannKind Completes Public Offering Of Common Stock And Warrants For US$92 Million 22
MannKind Completes Public Offering Of Units For US$86 Million 23
Debt Offering 25
MannKind Completes First Tranche Of Private Placement Of Notes For US$40 Million 25
MannKind Corp – Key Competitors 27
MannKind Corp – Key Employees 28
MannKind Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Strategy And Business Planning 30
Sep 05, 2017: MannKind Relocates Headquarters to Westlake Village 30
Financial Announcements 31
Aug 02, 2018: MannKind Reports 2018 Second Quarter Financial Results Conference Call to Begin Today at 5:00 PM ET 31
May 09, 2018: MannKind Reports 2018 First Quarter Financial Results 33
Feb 27, 2018: MannKind Reports 2017 Fourth Quarter and Full Year Financial Results 34
Aug 07, 2017: MannKind Reports 2017 Second Quarter Financial Results 36
May 10, 2017: MannKind Reports 2017 First Quarter Financial Results 38
Mar 16, 2017: MannKind Reports 2016 Fourth Quarter and Full Year Financial Results 39
Corporate Communications 40
Feb 06, 2018: MannKind Names David Kendall As Chief Medical Officer 40
Jul 17, 2017: Steven Binder Joins MannKind as Chief Financial Officer 41
Jul 12, 2017: Patrick McCauley Joins MannKind as Chief Commercial Officer 42
Jun 28, 2017: Mannkind draws remaining funds under mann group loan arrangement 43
Jan 04, 2017: MannKind Announces Key Addition to Its Executive Management Ranks 44
Legal and Regulatory 45
Jun 25, 2018: MannKind Set to Join Russell 3000 Index 45
Other Significant Developments 46
Jan 03, 2017: MannKind Receives $1 Million Milestone From RLS 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
MannKind Corp, Medical Equipment, Key Facts, 2017 2
MannKind Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MannKind Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MannKind Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MannKind Corp, Deals By Market, 2012 to YTD 2018 9
MannKind Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
MannKind and One Drop to Enter into Agreement 11
United Therapeutics to Enter into Licensing Agreement with MannKind 12
MannKind Raises USD28 Million in Private Placement of Shares 13
Mannkind to Raise USD61 Million in Private Placement of Shares 15
MannKind Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 17
MannKind Raises USD36.2 Million in Private Placement of Shares 18
Mannkind Raises USD50 Million in Private Placment of Shares 19
MannKind Announces Public Offering Of Common Stock For US$50 Million 21
MannKind Completes Public Offering Of Common Stock And Warrants For US$92 Million 22
MannKind Completes Public Offering Of Units For US$86 Million 23
MannKind Completes First Tranche Of Private Placement Of Notes For US$40 Million 25
MannKind Corp, Key Competitors 27
MannKind Corp, Key Employees 28
MannKind Corp, Other Locations 29
MannKind Corp, Subsidiaries 29

List of Figures
MannKind Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MannKind Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MannKind Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
MannKind Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MannKind Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[MannKind Corp (MNKD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hyposwiss Private Bank Geneve SA:企業の戦略・SWOT・財務情報
    Hyposwiss Private Bank Geneve SA - Strategy, SWOT and Corporate Finance Report Summary Hyposwiss Private Bank Geneve SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Deli Management, Inc. :企業の戦略・SWOT・財務情報
    Deli Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Deli Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Compuware Corp:企業の戦略・SWOT・財務情報
    Compuware Corp - Strategy, SWOT and Corporate Finance Report Summary Compuware Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • University of Oxford-製薬・医療分野:企業M&A・提携分析
    Summary University of Oxford (UO) is a research and educational university that offers student training, academic research and graduation programs. The university offers graduation courses in the various fields such as humanities, mathematical, physical and life sciences; medical sciences, and conti …
  • Sandoz International GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Sandoz International GmbH (Sandoz), a subsidiary of Novartis AG develops, manufactures and commercializes generic pharmaceutical products. The company provides biosimilars, generic antibiotics, dermatology and transplantation medicines. Its biosimilars comprise Omnitrope, Binocrit and Zarzio …
  • Engie SA (ENGI):石油・ガス:M&Aディール及び事業提携情報
    Summary Engie SA (Engie) is an electric utility. It provides electricity, natural gas, and energy services. It generates electricity from hydro, wind, biomass, and solar sources, and trades and sells that energy; supplies, distributes, trades, and sells natural gas; and offers a comprehensive range …
  • The Allstate Corporation:戦略・SWOT・企業財務分析
    The Allstate Corporation - Strategy, SWOT and Corporate Finance Report Summary The Allstate Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • The Nippon Synthetic Chemical Industry Co Ltd:企業の戦略的SWOT分析
    The Nippon Synthetic Chemical Industry Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Fluor Corp (FLR):企業の財務・戦略的SWOT分析
    Fluor Corp (FLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Medical Facilities Corp (DR):企業の財務・戦略的SWOT分析
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • Telstra Corporation Ltd (TLS):企業の財務・戦略的SWOT分析
    Telstra Corporation Ltd (TLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • The Lubrizol Corp:企業の戦略的SWOT分析
    The Lubrizol Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Hindustan ZInc Ltd:企業の戦略・SWOT・財務分析
    Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nippon Paint Holdings Co Ltd (4612):企業の財務・戦略的SWOT分析
    Nippon Paint Holdings Co Ltd (4612) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • AutoZone Inc (AZO):企業の財務・戦略的SWOT分析
    AutoZone Inc (AZO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Etablissementen Franz Colruyt NV (COLR):企業の財務・戦略的SWOT分析
    Etablissementen Franz Colruyt NV (COLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Eiffage SA (FGR):電力:M&Aディール及び事業提携情報
    Summary Eiffage SA (Eiffage) is a construction and concession company. It operates in businesses of energy and infrastructure construction, real estate development, road construction, civil engineering, concessions, and public-private partnerships. The company’s activities include construction, reno …
  • Baxter International Inc (BAX)-製薬・医療分野:企業M&A・提携分析
    Summary Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products. It undertakes the development, manufacture and marketing of medical products for the treatment of end-stage renal diseases. Its portfolio include a comprehensive range of home, acute and in-cent …
  • Newfoundland Power Inc:企業の戦略的SWOT分析
    Newfoundland Power Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Vior Inc (VIO):企業の財務・戦略的SWOT分析
    Summary Vior Inc (Vior) is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, and development of gold and silver metal properties in North and Latin America. Its projects comprise Mosseau Gold project, Foothills Rutile project, Vezza-Noyard Go …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆